An employee hands back a positive marijuana result and says they never smoked, they were just in the room with people who did. It is one of the most common explanations an employer or a medical review officer hears, and it puts both sides in an awkward spot. The person may be telling the truth about what happened in the room. Whether that explanation holds up against a positive urine test is a separate question, and it has a fairly clear answer once you understand how cutoff levels work and what the research on passive exposure actually shows.
The short answer
Under realistic, everyday conditions, sitting near someone smoking marijuana, riding in a car with the windows cracked, standing near a smoking area outside a venue, secondhand exposure does not push urine THC metabolite levels anywhere close to a standard drug test cutoff. The scenario where passive exposure can register a measurable, low level result requires conditions most people never encounter: a small, sealed room, heavy and continuous smoke for an extended period, and no ventilation. Even then, the levels involved sit well below what most workplace and forensic cutoffs are designed to catch, and federal guidance does not treat passive exposure as an acceptable explanation for a confirmed positive result at the standard cutoff.
How a urine drug test is actually built to filter out background exposure
Federal workplace drug testing does not rely on a single number. It uses a two stage process, an initial screening test followed by a confirmatory test, and the two stages use different cutoff concentrations for exactly this reason. The initial immunoassay screen for marijuana metabolites is set at 50 nanograms per milliliter, and any specimen that screens positive at that level moves to a confirmatory test using gas chromatography-mass spectrometry, which has its own, lower cutoff of 15 nanograms per milliliter for the specific marijuana metabolite THCA. Both cutoff concentrations are published in the Department of Transportation's testing regulations at 49 CFR 40.85, which governs cutoff levels for all federally regulated urine drug testing programs.
| Test stage | Analyte tested | Cutoff concentration | Purpose |
|---|---|---|---|
| Initial screen (immunoassay) | Marijuana metabolites (THCA) | 50 ng/mL | Fast, low cost first pass that flags specimens needing further review |
| Confirmatory test (GC-MS/MS) | THCA specifically | 15 ng/mL | Precise, legally defensible identification and quantification before a result is reported positive |
That two step design exists because a screening test alone is not specific enough to rely on for an employment or legal decision. The gap between the two cutoffs also matters here. A specimen has to clear both the higher screening threshold and the lower, more specific confirmatory threshold before a lab reports a positive marijuana result. That built in margin is part of why casual, background exposure almost never produces a confirmed positive.
What the research on passive cannabis smoke exposure actually shows
Researchers have studied secondhand marijuana exposure for decades, going back to controlled studies in the 1980s and continuing through more recent work funded by federal agencies. The general pattern across that body of research is consistent. Under normal, ventilated conditions, exposure to someone else's marijuana smoke produces urine THC metabolite concentrations that stay far below the 50 ng/mL screening cutoff, typically near the lower limit of what a lab assay can even detect. The federal government reviewed this research directly when it revised its workplace drug testing rules, citing controlled exposure studies on nonsmokers in unventilated versus ventilated rooms in the preamble to its 2017 Mandatory Guidelines for Federal Workplace Drug Testing Programs.
The conditions where a measurable result becomes possible are deliberately extreme, not accidental. Small, sealed spaces with no air exchange, hours of continuous heavy smoke, and close physical proximity to multiple people smoking are the scenarios researchers have used to test the outer edge of passive exposure. Even in those setups, results tend to be low and short lived rather than a robust, sustained positive. A car ride with the windows down, a smoky bar, a family gathering where someone steps outside to smoke, or living with a roommate who smokes occasionally in another room are nowhere near the exposure levels those studies were built to produce. For general background on how THC is absorbed and metabolized in the body, the National Institute on Drug Abuse maintains a plain language overview at its marijuana DrugFacts page.
Federal rules do not accept passive exposure as a legitimate explanation
This is the part employers and employees both need to understand clearly. Even accounting for the extreme-exposure research, federal drug testing regulation does not treat passive exposure as an acceptable medical explanation for a confirmed positive marijuana result at the standard cutoff. The regulation governing what a medical review officer can and cannot accept as a legitimate explanation specifically addresses this. Under 49 CFR 40.151, a medical review officer is instructed that stories involving passive or unknowing exposure, such as being in a car with people smoking, are not verifiable and do not constitute a legitimate medical explanation for a positive result, even if the story is true. The reasoning is straightforward. The cutoffs were set specifically to separate active use from background environmental exposure, so a confirmed positive at those cutoffs already reflects a concentration the science says passive exposure does not typically reach.
Confirmation testing is the real safeguard, not the explanation offered
The protection against a genuine false positive is not accepting an employee's account of what happened in the room, it is the testing process itself. A specimen that screens positive on the initial immunoassay is never reported to an employer as a final result without first going through confirmatory testing at a certified laboratory, followed by review from a qualified medical review officer, a licensed physician trained specifically to evaluate non-negative results. That review process, covered in more detail in this breakdown of how medical review officers verify a drug test result, exists precisely so that a lab number is never treated as a final employment decision on its own. The medical review officer contacts the donor, asks about prescriptions and medical conditions, and applies the same regulatory standards that exclude passive exposure as an acceptable explanation before a result is ever reported as verified positive.
This layered process is also why other incidental exposure claims, like hemp or CBD product use, get handled through documentation rather than assumption. CBD products can carry trace THC that occasionally does register on a screen, which is a different mechanism than secondhand smoke but raises a similar question for employers about how to evaluate an unverified claim. That scenario is covered separately in this look at whether CBD use can show up on a drug test, and the same underlying principle applies in both cases: the lab confirmation and MRO review carry the weight, not the employee's account.
What employers should actually do when someone claims secondhand exposure
An employer who hears a secondhand exposure claim should not treat it as automatically credible or automatically dismissible. The correct response is to let the built in process run as designed rather than making a judgment call outside of it.
- Confirm the specimen went through both the initial screen and the confirmatory GC-MS/MS test before treating the result as final. A screening only result should never be the basis for a decision.
- Route any non-negative result through a certified medical review officer rather than evaluating the explanation internally. The MRO applies consistent federal standards to explanations like passive exposure, so the decision does not rest on a supervisor's judgment call.
- Keep the process the same regardless of how plausible an explanation sounds. Treating one employee's secondhand smoke story differently than another's creates inconsistency that becomes a liability later, whether or not the explanation happens to be true.
- Document the verified result and the MRO's determination, not the employee's narrative, as the basis for any employment action.
Employers building or reviewing a marijuana testing program from the ground up should make sure the collection and confirmation steps are actually in place before a borderline claim ever comes up, using proper workplace drug testing supplies and programs that support the full screen to confirmation pipeline rather than relying on a screening cup alone. A program that skips confirmatory testing to save time or cost is the one most likely to end up disputing a result it cannot actually defend.
Frequently asked questions
Can riding in a car with someone smoking marijuana make me fail a drug test?
Under normal conditions, no. Studies on passive cannabis smoke exposure consistently find that realistic, ventilated exposure, including car rides, produces urine THC concentrations far below the standard 50 ng/mL screening cutoff.
Is there any situation where secondhand marijuana smoke could cause a positive result?
Only under extreme conditions that are uncommon outside a controlled research setting, such as hours of exposure in a small, sealed room with no ventilation. Even then, federal regulation does not accept passive exposure as a legitimate explanation for a confirmed positive at the standard cutoff.
What happens if an employee tells the medical review officer they were only around secondhand smoke?
The MRO reviews the explanation against federal standards, which specifically exclude passive or unknowing exposure stories as a legitimate medical explanation for a confirmed positive marijuana result, since those accounts cannot be independently verified.
How is a secondhand exposure claim different from a CBD product claim?
They involve different mechanisms, incidental smoke inhalation versus trace THC in a hemp derived product, but both are treated the same way procedurally. Neither is accepted at face value, and both are evaluated through confirmatory testing and MRO review rather than the employee's account alone.
Does a positive screening test alone mean someone failed a drug test?
No. A screening result is preliminary. It must be confirmed through GC-MS/MS testing at a certified laboratory and reviewed by a medical review officer before it becomes a verified result that an employer can act on.
Related reading
This article is general information, not medical or legal advice. Drug testing cutoff levels, laboratory procedures, and medical review officer standards are set by federal regulation and can be updated over time, so employers and employees should confirm current requirements with a qualified medical review officer or employment counsel before relying on any specific claim about a test result.
